Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Svennilson Peter
Relationship:   Director, 10% Owner
City:   Seattle
State:   WA
   
Insider Summary:
  
   
Companies Owned :   8    
Direct Shares   21,988,435    

Indirect Shares

   28,546,447      
Direct Value   $116,384,489    

Indirect Value

   $275,023,661      
Total Shares   50,534,882      
Total Value   $391,408,150      


Constellation Pharmaceuticals Inc $87,862,688 Ngm Biopharmaceuticals Inc $27,702,818 Revolution Medicines, Inc. $818,983 Nurix Therapeutics, Inc. $0 Constellation Pharmaceuticals Inc $87,862,688 Ngm Biopharmaceuticals Inc $27,702,818 Revolution Medicines, Inc. $818,983 Nurix Therapeutics, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    32   
    4    

     Stock price went up :
    32   
    1    
     Stock price went down :
    0   
    3    
   
     Gain/Loss Ratio :
   32.0   
   32.0   
     Percentage Gain/Loss :
   66.6%
 -51.4%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Immune Design Corp. IMDZ Managing Partner, 10% ... 2019-04-02 0 2017-10-27 6,642,942    Premium*  
            Constellation Pharmaceuticals Inc CNST 10% Owner 2021-02-17 2,584,957 2021-02-17 3,645,681    Premium*  
            Gritstone Oncology, Inc. GRTS Director, 10% Owner 2018-10-02 0 2018-10-02 3,102,934    Premium*  
            Ngm Biopharmaceuticals Inc NGM Managing Partner, 10% ... 2020-08-28 17,988,843 2020-08-28 190,000    Premium*  
            Oric Pharmaceuticals, Inc. ORIC Director, 10% Owner 0 2020-04-28 4,768,181    Premium*  
            Revolution Medicines, Inc. RVMD Director 2021-04-28 20,302 2021-04-28 3,145,258    Premium*  
            Nurix Therapeutics, Inc. NRIX 10% Owner 2021-05-05 1,394,333 2021-05-05 1,420,954    Premium*  
            Rapt Therapeutics, Inc. RAPT Director, 10% Owner 2020-08-17 0 2020-09-22 5,630,497    Premium*  
* Premium Members only  

Records found :    116         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 4 of 5
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-03-02 4 B $17.90 $252,820 I/I 14,124 16,555,300 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-03-03 4 B $17.99 $697,256 I/I 38,758 16,594,058 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-03-04 4 B $17.96 $179,349 I/I 9,986 16,604,044 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-03-05 4 B $18.00 $149,526 I/I 8,307 16,612,351 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-03-19 4 B $11.59 $1,720,698 I/I 148,464 16,760,815 2.25 %
CNST Constellation Pharmaceuti... Managing Partner   –       –       •   2020-03-19 4 B $22.38 $808,701 D/D 36,135 6,045,837 2.45 %
CNST Constellation Pharmaceuti... Managing Partner   –       –       •   2020-03-20 4 B $23.15 $128,228 D/D 5,539 6,051,376 2.45 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-03-20 4 B $11.77 $1,684,075 I/I 143,082 16,903,897 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-03-23 4 B $11.63 $1,981,601 I/I 170,387 17,074,284 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-03-24 4 B $12.22 $1,568,767 I/I 128,377 17,202,661 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-03-25 4 B $12.49 $30,176 I/I 2,416 17,205,077 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-03-31 4 B $12.53 $1,479,380 I/I 118,067 17,323,144 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-04-01 4 B $12.26 $1,447,501 I/I 118,067 17,441,211 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-04-02 4 B $12.40 $184,140 I/I 14,850 17,456,061 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-04-03 4 B $12.41 $181,025 I/I 14,587 17,470,648 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-04-07 4 B $14.38 $1,779,209 I/I 123,728 17,594,376 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-04-08 4 B $14.95 $1,683,400 I/I 112,602 17,706,978 2.25 %
NGM Ngm Biopharmaceuticals In... General Partner   –       –       •   2020-07-24 4 B $17.93 $1,232,670 D/D 68,749 1,609,013 2.45 %
NGM Ngm Biopharmaceuticals In... General Partner   –       –       •   2020-07-27 4 B $17.99 $68,974 D/D 3,834 1,612,847 2.45 %
NGM Ngm Biopharmaceuticals In... General Partner   –       –       •   2020-07-28 4 B $17.99 $73,849 D/D 4,105 1,616,952 2.45 %
NGM Ngm Biopharmaceuticals In... General Partner   –       –       •   2020-07-30 4 B $17.99 $13,169 D/D 732 1,617,684 2.37 %
NGM Ngm Biopharmaceuticals In... General Partner   –       –       •   2020-08-13 4 B $17.89 $355,922 D/D 19,895 1,637,579 2.45 %
NGM Ngm Biopharmaceuticals In... General Partner   –       –       •   2020-08-14 4 B $17.49 $664,498 D/D 37,993 1,675,572 2.45 %
NGM Ngm Biopharmaceuticals In... General Partner   –       –       •   2020-08-17 4 B $17.89 $114,943 D/D 6,425 1,681,997 2.45 %
NGM Ngm Biopharmaceuticals In... General Partner   –       –       •   2020-08-21 4 B $17.97 $131,558 D/D 7,321 1,689,318 2.45 %
  116  Records found
  1   2   3   4  5      
  Page 4 of 5  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us